Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent A Griffith

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumorsAnne F Schott, Melissa D Landis, Gabriela Dontu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2023
Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)Arathi Mohan, Kent A Griffith, Fulei Wuchu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2021
Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational CohortReshma Jagsi, Kent A Griffith, Frank A Vicini, et al.
Blood|June 6, 2012
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myelomaAndrzej J Jakubowiak, Dominik Dytfeld, Kent A Griffith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancerCostanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2023
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEAReshma Jagsi, Kent A Griffith, Eleanor E Harris, et al.
Cancer|May 31, 2013
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancerEdward J Kim, Edgar Ben-Josef, Joseph M Herman, et al.
JCO Oncology Practice|May 23, 2023
Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology PracticesReshma Jagsi, Krithika Suresh, Chris D Krenz, et al.
Practical Radiation Oncology|May 28, 2021
Contemporary Practice Patterns for Palliative Radiation Therapy of Bone Metastases: Impact of a Quality Improvement Project on Extended FractionationElizabeth M Jaworski, Huiying Yin, Kent A Griffith, et al.
Blood|August 1, 2020
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myelomaJagoda K Jasielec, Tadeusz Kubicki, Noopur Raje, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumorsAnne F Schott, Melissa D Landis, Gabriela Dontu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2023
Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)Arathi Mohan, Kent A Griffith, Fulei Wuchu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2021
Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational CohortReshma Jagsi, Kent A Griffith, Frank A Vicini, et al.
Blood|June 6, 2012
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myelomaAndrzej J Jakubowiak, Dominik Dytfeld, Kent A Griffith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancerCostanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2023
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEAReshma Jagsi, Kent A Griffith, Eleanor E Harris, et al.
Cancer|May 31, 2013
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancerEdward J Kim, Edgar Ben-Josef, Joseph M Herman, et al.
JCO Oncology Practice|May 23, 2023
Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology PracticesReshma Jagsi, Krithika Suresh, Chris D Krenz, et al.
Practical Radiation Oncology|May 28, 2021
Contemporary Practice Patterns for Palliative Radiation Therapy of Bone Metastases: Impact of a Quality Improvement Project on Extended FractionationElizabeth M Jaworski, Huiying Yin, Kent A Griffith, et al.
Blood|August 1, 2020
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myelomaJagoda K Jasielec, Tadeusz Kubicki, Noopur Raje, et al.
Pageof 18